- Home
- News
- Topics
- FDA Week
- Inside CMS
- Inside Drug Pricing
- Health Exchange Alert
- Inside TeleHealth
- About Us
rs DRUG COMPETITION ACT OF 2001 -- (Senate - November 18, 2002) [Page: S11339] The PRESIDING OFFICER. The clerk will report the bill by title. [Strike the part shown in black brackets and insert the part shown in Italic.] Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled, [SECTION 1. SHORT TITLE. [SEC. 2. FINDINGS.
rk
BIO STATEMENT ON PRODIGENE, INC.
For Immediate Release
11/15/02
Contact:
Lisa Dry
Direct (202) 962-9231
Cell (202) 345-3673
WASHINGTON, D.C. (November 15, 2002) - Biotechnology Industry Organization (BIO) Executive Director for Food and Agriculture Michael J. Phillips today issued the following statement regarding regulatory infractions by ProdiGene, Inc. as announced by the Animal Plant Health and Inspection Service of the U.S. Department of Agriculture:
sm
After an extensive external and internal search, it is with great pleasure we announce that Dr. Mary Purucker has accepted the offer to become CDER's first Division Director for Counter-Terrorism. Dr. Purucker will begin her new position December 2, 2002. She brings to the position excellent scientific and clinical training, extensive regulatory experience and a strong commitment to public health and the Commissioned Corps.
CONFERENCE ANNOUNCEMENT
Contact: Diane Dorman
Examining the Roadmap to Therapeutically
Equivalent Biologics
Danbury, Connecticut, November 18, 2002 -- The National Organization for Rare Disorders (NORD) announced today it will hold a one-day conference in March 2003 to explore the scientific, economic, and regulatory feasibility of developing and marketing therapeutically equivalent biologics. There is currently no regulatory pathway at the U.S. Food and Drug Administration for doing this after patents expire.
CDC released its latest update on the recent outbreak of Listeriosis in the northeastern United States. The outbreak, effecting 52 people to date, has been linked to ready-to-eat poultry products produced by Pilgrim's Pride Corporation and Jack Lambersky Poultry Company. Click here for the CDC Release
en
FDA Talk Papers are prepared by the Press Office to guide FDA personnel in responding with consistency and accuracy to questions from the public on subjects of current interest. Talk Papers are subject to change as more information becomes available.
T02-45
Media Inquiries: 301-827-6242
November 18, 2002
Consumer Inquiries: 888-INFO-FDA
FDA CLEARS NEW LAB TEST FOR GROUP B STREP IN PREGNANT WOMEN
The Food and Drug Administration today cleared for marketing a new laboratory test for Group B Streptococcus in pregnant women.
ds
FOR IMMEDIATE RELEASE
Contact: Judy Blatman at 202-263-1005
WASHINGTON, D.C., November 19, 2002 - The Council for Responsible Nutrition (CRN), one of the dietary supplement industry's leading trade associations, today commended the American Heart Association (AHA) for urging people to consume omega-3 fatty acids to protect their hearts.